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SUMMARY
Lin et al. (http://www.biostatsresearch.com/upennbiostat/papers/, 2006) proposed a nested Markov com-
pliance class model in the Imbens and Rubin compliance class model framework to account for time-
varying subject noncompliance in longitudinal randomized intervention studies. We use superclasses, or
latent compliance class principal strata, to describe longitudinal compliance patterns, and time-varying
compliance classes are assumed to depend on the history of compliance. In this paper, we search for good
subject-level baseline predictors of these superclasses and also examine the relationship between these
superclasses and all-cause mortality. Since the superclasses are completely latent in all subjects, we utilize
multiple imputation techniques to draw inferences. We apply this approach to a randomized intervention
study for elderly primary care patients with depression. Copyright q 2007 John Wiley & Sons, Ltd.
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1. INTRODUCTION
In longitudinal randomization studies where subjects are randomized at baseline and interven-
tions are administered repeatedly over time, subject adherence to intervention may vary over time.
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In [1] (Lin, Ten Have, and Elliott, LTE), we examined the relationship between longitudinal
intervention compliance and depression outcomes in the Prevention of Suicide in Primary Care
Elderly: Collaborative Trial (PROSPECT) [2]. In this paper, we are interested in the subject-
level baseline predictors of longitudinal intervention compliance, and the relationship between
longitudinal intervention compliance and mortality.
The PROSPECT study was a randomized intervention study targeting elderly patients in primary
care clinics with depression. There were two intervention arms: usual care and the intervention.
In the usual care arm, patients received standard care. In the intervention arm, patients were
assigned to meet with health specialists who educated patients, their families, and physicians
about depression, treatment, and monitored adherence to the intervention. Primary care clinics
were randomized to the intervention arms rather than individual patients to prevent contamination
of interventions between patients within the same clinic and for practicality. Subject adherence
to meeting with health specialists were measured at five time points over a two-year period, and
adherence could vary over time.
Angrist et al. [3] and Imbens and Rubin [4] proposed using latent compliance classes to account
for subject noncompliance in the context of cross-sectional randomized treatment studies. In studies
where there are treatment noncompliance, the relationship between treatment randomization and
outcomes may be confounded by post-randomization treatment adherence. Compliance classes
are considered baseline factors, and utilizing them allows us to examine the relationship between
post-randomization treatment adherence and outcomes.
In a two-arm randomized intervention study with an usual care arm and an intervention arm there
are four possible compliance classes: complier, always-taker, never-taker, and defier. Compliers are
those that would adhere to the intervention to which they are randomly assigned; always-takers are
those that would choose to receive the intervention regardless of their randomization assignment;
never-takers are those that would choose to receive the usual care regardless of their randomization
assignment; and defiers are those that would follow the regime opposite the arm to which they
are assigned. These compliance classes are latent because those randomized to and who follow
the usual care regime could be compliers or never-takers; those randomized to and who follow
the intervention regime could be compliers or always-takers; those randomized to the usual care
but who follow the intervention regime could be always-takers or defiers; those randomized to the
intervention but who refused the intervention, and instead follow the usual care regime, could be
never-takers or defiers.
In studies such as PROSPECT where there are two intervention arms and subjects randomized
to the usual care arm have no access to the intervention, there are only two possible compliance
classes: compliers and never-takers. Since those randomized to the usual care group have no access
to the intervention, there are no always-takers or defiers by definition. In this study design, the
compliance classes are observed in those randomized to the intervention arm but are latent in
those randomized to the usual care arm. Subjects randomized to the usual care arm can only
be observed to follow the usual care regime; therefore, they could be compliers or never-takers.
Subjects randomized to the intervention arm and observed to follow the intervention regime are
compliers, and those observed to follow the usual care regime are never-takers.
In LTE [1] we extended the Imbens and Rubin [4] compliance class model to longitudinal studies
where subjects are randomized at baseline and randomization status stays constant over time but
adherence to the intervention could vary over time. With two possible compliance classes and five
time points, we have a total of 32 (25) possible longitudinal compliance patterns. The proposed
principal stratification strategy uses principal strata [5, 6] (PS), or ‘compliance superclasses’, to
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summarize the longitudinal compliance patterns in the data, within which intent-to-treat contrasts
are made to estimate the effect of the intervention on the depression outcome to account for
intervention noncompliance.
In this paper, we are focusing on the compliance superclass and how they relate to baseline
patient characteristics and all-cause mortality. We may make inferences on each of the longitudinal
compliance patterns. However, such inferences may be sensitive to model assumptions when the
number of subjects exhibiting each of the patterns are small, and inferences on such specific
groups may be impractical and not clinically meaningful. It may be more useful to summarize
the longitudinal compliance patterns with broader PS, or superclasses, and look at the relationship
between the superclasses and baseline patient characteristics and mortality. Use of latent classes to
summarize longitudinal patterns of adherence has been done on observed adherence to prescribed
medication in the PROSPECT [7].
It is of clinical importance to identify baseline patient characteristics that relate to intervention
adherence. If clinicians can identify patients who are likely to comply with particular interventions,
it allows them to target those that are most likely to benefit from the interventions. If clinicians can
identify patients who are less likely to comply with interventions, they can modify the interventions
or offer extra incentive to increase patient compliance.
Previous research suggests that depression is associated with increased risk of death [8, 9], and
there may be an association between treatment adherence and mortality [10–13]. We are interested
in examining the relationship between longitudinal intervention compliance and all-cause mortality.
We obtained subjects’ vital status from the National Death Index, and continued to follow subjects
after the PROSPECT study concluded.
For those subjects randomized to the intervention arm in the PROSPECT, their time-varying
compliance classes are observed. Alternative to classifying subjects using latent compliance su-
perclasses is to classify subjects into pre-specified observed PS based on observed time-varying
compliance classes for those randomized to the intervention arm. Such PS could be subjects who
complied with their randomization throughout the entire study period (perfect compliers) and ones
who did not. In this paper, we compare baseline subject characteristics and mortality between
latent compliance superclasses, then we compare the results to those based on observed PS among
subjects randomized to the intervention arm.
We define notations in Section 2, and discuss analysis methods and details of the models in
Section 3. We present the analysis results in Section 4, and finally make concluding remarks in
Section 5.
2. NOTATION
Let Zi denote the randomization status for subject i where i = (1, . . . , N ), and Zi ∈ (0, 1) for
randomized to the usual care and the intervention arm, respectively. Let Di j denote the actual
intervention received for subject i at time j where j = (1, 2, 3, 4, 5) for 4-, 8-, 12-, 18-, and
24-month follow-up, respectively, and Di j ∈ (0, 1) for usual care and intervention, respectively.
Note that subjects are only randomized at baseline; therefore, Zi does not have a subscript j . Let
Yi j denote the outcome for subject i at time j . The partially latent compliance classes for subject
i at time j is denoted by Ci j where Ci j ∈ (c, n) for complier and never-taker, respectively. Let
Ui denote membership of the latent compliance superclass for subject i , where Ui = (1, . . . , K )
for assumed K numbers of superclasses. Let Qi denote vector of baseline covariates for subject i
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associated with intervention compliance, and Ai denote vector of baseline covariates associated
with depression outcome.
3. ANALYSIS METHOD
In this analysis we implement a three-stage method. In the first stage, we fit the Markov nested
compliance class model proposed in LTE [1] to describe the subject longitudinal intervention com-
pliance behavior in the PROSPECT using latent compliance superclasses. In the second stage we
treat the latent compliance superclasses as missing data, and utilize multiple imputation techniques
with information from the Markov chain Monte Carlo (MCMC) chains in the first stage. In the
third stage we relate the multiply imputed compliance superclass to baseline subject characteristics
and all-cause mortality. We proceed to describe the latent compliance class and superclass model
in stage 1, the incomplete data model in stage 2, and the complete data model in stage 3.
3.1. Stage 1: Compliance principal stratification
In the first stage we use the non-stationary Markov compliance class (MCC) model proposed in
LTE [1] to describe time-varying compliance behavior. Latent compliance superclasses are used
to summarize latent longitudinal compliance class patterns. We assume subject compliance su-
perclass (Ui = k)∼Multinomial(1, pk) where ∑k pk = 1. The MCC model assumes that subjects’
compliance behavior is related to their history of compliance. More specifically, subject compli-
ance is modeled as dependent on compliance in the previous follow-up period, latent compliance
superclass, and baseline covariates
P(Ci1, . . . ,Ci5|Ui ,Qi ) = P(Ci1|Ui ,Qi )P(Ci2|Ci1,Ui ) . . . P(Ci5|Ci4,Ui ) (1)
The time-varying compliance probabilities are estimated from the compliance probabilities at the
first follow-up and the time-varying compliance class transitional probabilities. To account for the
relationship between baseline covariates and subject intervention compliance, we include baseline
covariates Qi in modeling the compliance probability at the first follow-up using a multinomial
logit model
P(Ci1 = |Ui = k,Qi ) = k(Qi )
k(Qi ) = exp(0k + a1Qi )[∑
′ exp(0k′ + a1′Qi )
] , ∑

k(Qi ) = 1 ∀k (2)
The 0k and a1 for one of the compliance class  are constrained to 0 for identifiability.
We assume the compliance class transition (Ci j = |Ci, j−1 = ′,Ui = k) ∼Multinomial(1, k j′)
where
∑
 k j′ = 1 ∀k, j, ′.
The main outcome of the study is the Hamilton Depression Rating Scale (HAMD). It measures
depression severity, with higher scores indicating more severe depression. It was measured at each
of the follow-up visits for each patient. We assume outcomes within an individual are indepen-
dent given randomization, time-varying compliance classes, baseline covariates, and subject-level
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random effect
(Yi j |Ci1, . . . ,Ci j , Zi = z,Ai ,Wi , k, c,ui , 2) ind∼ N(i j z, 2)
i j z =
∑
′
[I (Ci j = ′, Zi = z) j′z] + ATi c+ WTi ui (3)
The conditional mean of the outcome has three components: compliance class-specific effect
of randomization, the effect of baseline covariates, and the subject-specific random effect to
account for within-subject correlation in the repeatedly measured outcomes. The compliance class-
specific effect of randomization on the outcome is represented by
∑
′ [I (Ci j = ′, Zi = z) j′z], and
k denotes the vector of  j′z parameters. The effect of the baseline covariates on the outcome
is represented by ATi c where Ai denotes the vector of baseline covariates of subject i , and the
column vector c denotes the corresponding coefficients. The random effect ui is used to account
for within-subject correlation in the outcomes, where Wi denotes the random-effect design matrix
for subject i . We consider a random subject-level intercept model.
In fitting the compliance class model we assume two latent compliance superclasses (Ui = (1, 2)).
Let Qi be the baseline HAMD score, and Ai be the baseline HAMD and baseline suicidal ideation.
Model parameters are estimated using Bayesian MCMCmethod. Gibbs sampling [4, 14–16] is used
to obtain draws from the posterior distributions of the parameters. The priors used in the estimation
are described in the Appendix. The posterior distributions of the a= (0k, a1) parameters are
not of a known parametric form. Therefore, we use the Metropolis–Hasting algorithm [16, 17] to
draw the a parameters.
We plotted and assessed the posterior predictive mean residuals from the HAMD model (3)
and found no strong relationship with the posterior predictive means of i j z , baseline HAMD,
and baseline suicide ideation, and no significant departure from normality among the residuals.
However, there may be some weak evidence suggesting heteroscedasticity of the residual variance.
In the PROSPECT data, intervention received (Di j ) is missing for some patients at some time
points. We assume these missing values are 0, or have not met with the health specialists. To our
knowledge, all patients who met with the health specialists have outcomes recorded; therefore, it
is reasonable to assume that if there were no outcomes recorded, then the patient did not meet
with the health specialists. The outcome (Yi j ) is also missing for some patients at some time
points. We assume a latent ignorable missing data mechanism [18] and assume that data are
missing at random given latent compliance class and covariates. At each iteration of the MCMC
procedure, we impute the missing outcomes conditional on compliance classes, randomization,
baseline covariates, and subject-level random effect. We draw missing outcome Ymisi j for subject i
at time j from its posterior predictive distribution given current values of parameters Ci j ,  j′z ,
c, Wi , ui , 
2, and vector of observed outcomes Yobs
(Ymisi j |Yobs,Ci j , Zi = z,Ai ,Wi ,  j′z, c,ui , 2) ∼N(∗i j z, 2)
∗i j z =
∑
′
[I (Ci j = ′, Zi = z) j′z] + ATi c+ WTi ui (4)
Estimation in stage 1 was implemented using the statistical software R.
3.2. Stage 2: Incomplete data model
Longitudinal compliance superclass are latent for all subjects, so we essentially have a missing
data problem where all data are missing. From stage 1 we have an estimate for each model
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parameter at each iteration of the MCMC chain, from which we can compute posterior predictive
distributions of the compliance superclasses. We use multiple imputation technique to impute the
compliance superclasses based on their posterior predictive distributions. To improve computation
speed, we only save the compliance superclasses for every 25th iteration of the MCMC chain.
Some of the baseline subject characteristics were missing in the data. We use PROC MI in SAS
to multiply impute the missing baseline covariates at every iteration of the MCMC chain using all
other observed baseline covariates considered in the analysis.
3.3. Stage 3: Complete data models
Next, we use the multiple imputed compliance superclasses and baseline subject characteristics
from stage 2 to examine the relationship between longitudinal compliance, baseline subject charac-
teristics, and all-cause mortality. Specifically, we treat the compliance superclasses as the dependent
variable in examining the relationship between subject-level baseline characteristics and longitu-
dinal compliance, and treat the compliance superclasses as the independent variable in examining
the relationship between longitudinal compliance and mortality.
To assess the within-clinic correlation in a preliminary analysis, we used PROC NLMIXED
in SAS to run random-effects logistic regression models using observed perfect compliance in
those randomized to the treatment group as the outcome variable, and each of their baseline
covariates as the independent variable with a random intercept for each clinic. Then, we use
the estimated variance of the random effect of clinics to calculate the within-clinic correlation,
2/(2 + /3), where 2 is the between-clinic variance from the random-effects models. The
within-clinic correlation for the compliance superclass was notable (ranges from 0.25 to 0.26);
therefore, we use random-effects logistic regression models to account for within-clinic correlations.
Similarly, using PROC NLMIXEDwe ran frailty models with time-to-death as the outcome variable
and observed perfect compliance as the independent variable. We calculate the between-subject
variance the same way we calculated the between-clinic variance, then calculate the within-clinic
correlation. The within-clinic correlation for mortality was close to 0; hence, we ignore it for the
mortality analysis.
For the analysis relating each of the baseline covariates to the compliance superclass, we use
random-effects logistic regression model with clinic-level random intercept to account for the
within-clinic correlation of the compliance superclass
P(Ui = k|Xi ,Gl) = exp(0k + Xi1k + I (i ∈ l)Gl)∑K
k=1 exp(0k + Xi1k + I (i ∈ l)Gl)
(5)
where Xi is the subject-level baseline covariate of interest, l ∈ (1, . . . , L) denotes the lth clinic,
and Gl is the clinic-level random effect for the lth clinic. We assume 0k and 1k for one of the
compliance superclass is 0 for identifiability, and assume that the random effect Gl ∼N(0, 2G).




exp(0k + Xi1k + I (i ∈ l)Gl)∑K











The parameters are estimated by maximizing the marginal likelihood and using Gaussian quadrature
integration methods implemented with the SAS NLMIXED procedure. We use a cluster-specific
approach here rather than a population average approach (e.g. generalized estimating equations
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approach) because we are interested in describing the change in a subject’s compliance superclass
membership given change in the baseline covariates.
We use the survival function to assess the probability distribution for time to death. The survival
function conditional on compliance superclass is defined as S(t |Ui = k) = P(Tit |Ui = k), which
is the probability that a subject survives beyond time t given that the subject is in the kth compliance
superclass. The Kaplan–Meier estimate of the survival function is






where dkt∗ denotes the number of deaths occurring at time t∗ in compliance superclass k, and Nkt∗
denotes the number of subjects remaining in the study in compliance superclass k who have not
died prior to time t∗. The ratio dkt∗/Nkt∗ estimates the probability that death occurs between t∗
and the following observed event time given an individual survives up to time t∗ in compliance
superclass k.
We also use the hazard function to describe the rate of death. When there are no covariates, the
hazard rate can be defined as
h(t) = lim
t→0
P(tt∗t + t |t∗t)
t
which is the instantaneous rate of death at time t . The cumulative hazard, H(t) = ∫ t0 h(u) du,
can be estimated nonparametrically by
∑
t∗t dkt∗/Nkt∗ . Various models can be used to relate
covariates to hazard rates. We use the Cox proportional hazards model to examine the relationship
between compliance superclass and all-cause mortality. We assume the proportional hazards
h(t |Ui = k) = h0(t) exp(	k I (Ui = k)) (7)
where 	k for one of the compliance superclass (reference superclass) is assumed 0 for identifiability.
Let t1, . . . , tN denote the ordered time of death, U(i) denotes the compliance superclass of the
subject who died at time ti , and R(i) denotes the set of individuals who are still alive just prior to




k=1 exp(	k)I (U(i) = k)∑
i∗∈R(i)
∑K
k=1 exp(	k)I (Ui∗ = k)
(8)
The baseline hazard h0(t) is the hazard rate for subjects in the reference compliance superclass
and is estimated nonparametrically. The parameter 	k is estimated using maximum likelihood
method and interpreted as the log-relative risk of death for the kth superclass versus the reference
superclass.
Now we address how to pool parameter estimates across imputations. Let 
m be the parame-
ter of interest, which is 1k from the logistic regression model, Kaplan–Meier survival estimate
S(t |Ui = k), and 	k from the Cox model of the mth imputed data set, where m = 1, . . . , M . In
this analysis M = 300. Let 
̂m denote the estimate of 
m . We can summarize 
̂m across mul-
tiple imputations by calculating the mean and associated variance. The combined estimates of
the parameter of interest is 
̂ = (1/M)∑Mm=1 
̂m . There are two types of variability associated
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with the above estimate: within-imputation variance, and between-imputation variance. The aver-
age within-imputation variance is W = (1/M)∑Mm=1 var(
̂m). The between-imputation variance is
B = (1/(M − 1)) ∑Mm=1(
̂ − 
̂m)2. The total variance associated with 
̂ is W + ((M + 1)/M)B.
The parameter 








[19, p. 211]. However, when M is large (here, 300), the t-distribution is closely approximated by
the normal distribution.
4. RESULTS
4.1. Compliance principal stratification
In LTE [1] we assumed three latent compliance superclasses and found a very small class whose
behavior was hard to interpret clinically. We did not think analysis based on such small group
would lead to any meaningful conclusions with regard to their survival probabilities or predictors
of compliance. Thus, in this analysis we assume there are two latent compliance superclasses
(i.e. K = 2).
Table I shows the time-varying compliance probabilities at the sample average baseline HAMD
score of 18.1. The first latent compliance superclass consists of subjects who are slightly more likely
to comply with assigned intervention at the 4-month follow-up than not comply, and compliance
decreases over time (increasing noncompliers). The second latent compliance superclass consists
of subjects who are highly compliant during the first 18 months of the study with a small drop
in compliance during the last 6 months (high compliers). The mean posterior probabilities of
memberships in the increasing noncomplier and high complier superclasses and their associated
95 per cent credible intervals are 0.51 (0.36, 0.65), and 0.49 (0.35, 0.64), respectively.
The posterior means of the log odds of compliance at 4 months and their associated 95
per cent credible intervals within each of the latent compliance superclasses controlling for base-
line HAMD are −0.48 (−1.63, 0.69) and 4.61 (1.48, 9.89) for the increasing noncomplier and the
Table I. Posterior means and 95 per cent credible intervals (in parentheses) for the time and
latent compliance superclass-varying compliance probabilities assuming the average baseline
HAMD of 18.1 and latent compliance superclass probabilities.
Time (months) Increasing noncompliers High compliers
4 0.65 (0.55, 0.77) 0.99 (0.92, 1.00)
8 0.35 (0.21, 0.53) 0.99 (0.90, 1.00)
12 0.16 (0.00, 0.36) 0.99 (0.90, 1.00)
18 0.07 (0.02, 0.26) 0.98 (0.76, 1.00)
24 0.03 (0.01, 0.08) 0.80 (0.61, 1.00)
P(Ui = k) 0.51 (0.36, 0.65) 0.49 (0.35, 0.64)
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Table II. Posterior means and 95 per cent credible intervals (in parentheses) of the
transitional probabilities.
Ui j P(Ci, j = c|Ci, j−1 = c,Ui = k) P(Ci, j = c|Ci, j−1 = n,Ui = k)
Increasing 2 0.53 (0.33, 0.71) 0.01 (0.00, 0.07)
noncomplier 3 0.42 (0.00, 0.70) 0.00 (0.00, 0.02)
4 0.12 (0.00, 1.00) 0.05 (0.02, 0.09)
5 0.23 (0.03, 0.56) 0.01 (0.00, 0.04)
High 2 1.00 (1.00, 1.00) 0.06 (0.00, 1.00)
complier 3 1.00 (0.99, 1.00) 0.81 (0.00, 1.00)
4 0.98 (0.83, 1.00) 0.44 (0.00, 1.00)
5 0.82 (0.73, 1.00) 0.48 (0.00, 1.00)
high complier superclasses, respectively. This suggests that at the 4-month follow-up, those in the
increasing noncomplier superclass are less likely to comply with their intervention assignment, and
those in the high complier superclass are more likely to comply with their intervention assignment
controlling for baseline HAMD. In our compliance class model we assume that the association
between baseline HAMD and compliance probability at 4 months is the same across all latent
compliance superclasses. The log odds of 4-month compliance for a unit increase in the baseline
HAMD is 0.06 (0.01, 0.12) suggesting that those with more severe depression at baseline are more
likely to comply with their intervention assignment.
The latent transitional probabilities of the time-varying compliance within each latent compliance
superclass in Table II shows that both the increasing noncompliers and the high compliers are
more likely to be in the complier compliance class if they are in the complier class in the previous
follow-up period than if they are in the never-taker class and switch to complier class. Subjects
in the high complier superclass are much more likely to transition into the complier class than
subjects in the increasing noncomplier superclass. Few patients in the high complier superclass
switched from the never-taker class to the complier class, causing large variability in the transitional
probabilities; hence, we see the wide range in the credible intervals.
In the PROSPECT study, 320 of the 598 study subjects were randomized to the intervention
arm. Forty-six per cent (N = 147) of those 320 subjects are observed to be perfect compliers who
met with the health specialist throughout the entire study period.
4.2. Baseline patient characteristics
In this section, we explore the relationship between longitudinal compliance and selected baseline
subject characteristics that may be related to longitudinal intervention compliance, examining one
characteristic at a time.
We look at age, years of education, numbers of comorbidities measured by the Charlson Comor-
bidity Index, cognitive functioning measured by the Mini Mental State Examination, race in terms
of white or ethnic minority as defined by the respondent, sex, marital status, diagnosis of diabetes,
diagnosis of heart disease, smoking, diagnosis of major depression, and physical functioning mea-
sured by the physical component of the SF-36 health survey at baseline. We assume that those
with missing information on diagnosis of diabetes, heart diseases, and smoking at baseline do not
have those diagnoses or smoke.
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Table III. Summary of the baseline characteristics.
Covariate Per cent or Mean (SD) Min Max Missing N
Age (years) 70.2 (7.9) 60 94 0
Education (years) 12.7 (3.3) 0 25 0
Comorbidity (#) 3.0 (2.4) 0 12 0
Cognitive function 27.4 (2.7) 0 30 0
Minority race 30.0 0 1 0
Female 72.2 0 1 0
Married 37.1 0 1 0
Diabetes 21.0 0 1 0
Heart disease 20.0 0 1 0
Smoking 8.4 0 1 0
Major depression 66.0 0 1 0
SF-36 physical health 39.6 (13.1) 8.9 70 135
Table IV. Odds ratio of high complier superclass membership relative to increasing
noncomplier superclass membership with a unit change in the baseline characteristics.
Predictor OR (95 per cent CI)
Age (year) 0.99 (0.96, 1.02)
Education (year) 1.00 (0.94, 1.06)
Comorbidity (#) 0.94 (0.86, 1.03)
Cognitive function (1 patient) 1.05 (0.97, 1.14)
Minority race 0.81 (0.48, 1.37)
Female 0.98 (0.62, 1.55)
Married 0.98 (0.63, 1.52)
Diabetes 0.94 (0.58, 1.52)
Heart disease 0.90 (0.53, 1.53)
Smoking 1.08 (0.53, 2.18)
Major depression 0.84 (0.55, 1.28)
SF-36 physical health (10 patients) 1.18 (0.99, 1.41)
Eighteen subjects (3.0 per cent) with missing years of education, number of comorbidities, race,
and marital status were excluded from the analysis resulting in a sample of 580 subjects. The
baseline characteristics of the 580 analysis sample are described in Table III. Those included in
the analysis did not differ from those excluded from the analysis on age, cognitive functioning,
diagnosis of diabetes, diagnosis of cardiovascular diseases, smoking, and diagnosis of major
depression at baseline. However, those included in the analysis are more likely to be females
(72.2 per cent) than those excluded from the analysis (50.0 per cent; 21 = 4.24, p= 0.04). Of
the remaining 580 subjects, 135 had missing physical functioning scores but all other baseline
covariates were observed. Only missing physical functioning scores were multiply imputed. Age,
education, number of comorbidities, cognitive function, race, sex, marital status, diagnosis of
diabetes, diagnosis of heart disease, smoking, and diagnosis of major depression were used in the
imputation model for missing physical functioning scores.
Table IV shows the point estimates and the associated 95 per cent confidence intervals for
the odds ratio of high complier superclass membership versus increasing noncomplier superclass
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Table V. Odds ratio of observed perfect complier PS membership relative
to observed nonperfect complier PS membership with a unit change in the
baseline characteristics (intervention arm only).
Predictor OR (95 per cent CI)
Age (year) 0.97 (0.94, 1.00)
Education (year) 1.03 (0.96, 1.11)
Comorbidity (#) 0.88 (0.80, 0.97)
Cognitive function (1 patient) 1.07 (0.98, 1.17)
Minority race 0.73 (0.38, 1.40)
Female 1.03 (0.63, 1.71)
Married 1.03 (0.61, 1.74)
Diabetes 0.91 (0.52, 1.59)
Heart disease 0.51 (0.28, 0.94)
Smoking 0.96 (0.45, 2.05)
Major depression 0.91 (0.56, 1.49)
SF-36 physical health (10 patients) 1.37 (1.09, 1.71)
membership given a unit increase in each of the baseline covariates. A unit is defined as one
point in the original scales of the variables, except for the physical functioning scores where a
more clinically relevant unit is 10 points on the original scale. We found a marginally significant
association between physical functioning and latent compliance superclass. A higher score on
the physical component of the SF-36 indicates better physical health. The odds of high complier
superclass membership with a 10-point increase in the SF-36 physical score is 1.18 with 95
per cent confidence interval (0.99, 1.41). This suggests that healthier subjects may more likely be
highly compliant. We adjusted for multiple comparisons using Holm’s test, which has been shown
to protect the family-wise error rate [20]. Physical functioning remained marginally significant
after multiple comparisons adjustment.
Table V displays the odds ratio of being observed to be a perfect complier versus not a
perfect complier given a unit change in each of the baseline subject characteristics. We find
that better physical health is associated with observed compliance. Subjects with higher number
of comorbidities are less likely to be perfect compliers than subjects with lower number of
comorbidities (odds ratio 0.88 (0.80, 0.97)). Subjects with diagnoses of heart disease at baseline
are less likely to be perfect compliers than subjects without diagnoses (odds ratio 0.51 (0.28, 0.94)).
Subjects with higher SF-36 scores are more likely to be perfect compliers than subjects with lower
scores (odds ratio 1.37 (1.09, 1.71)). The associations between numbers of comorbidities and
physical functioning remained significant after a multiple comparisons adjustment using Holm’s
test.
The comparisons of baseline subject characteristics between latent compliance superclasses and
observed compliance PS yielded evidence that those with better physical functioning may more
likely be highly compliant than those with worse physical functioning. Previous research [21–24]
has shown that patient adherence to treatment is associated with ease of complying. In this analysis,
adherence to the intervention is defined by meeting with the health specialists at the clinics during
each of the follow-up periods. It may be easier for those in good physical health to go to the clinics
to meet with the health specialists than those in bad physical health. The comparisons based on
the observed compliance PS also showed that higher number of comorbidities and diagnoses of
heart disease at baseline are associated with lower compliance. Both these characteristics pertain
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to physical health. It is consistent with our reasoning that it may be easier for healthier subjects
to attend meetings with health specialists than subjects who are unhealthy.
4.3. Mortality
In this section we look at the relationship between all-cause mortality and longitudinal compliance.
Mortality data were obtained from the National Death Index. The mean follow-up time for mortality
status is 28.9 months with a standard deviation of 8.0 months. The minimum follow-up time is
0.8 months and maximum is 43.7 months.
Figure 1 displays the Kaplan–Meier survival curves stratified on the multiply imputed latent
compliance superclass, and Figure 2 displays the survival curves stratified on the observed compli-
ance PS. The bold lines in Figure 1 represent the mean Kaplan–Meier survival curves, calculated
from taking the averages of the survival estimates at each time point over the MCMC iterations.
The thinner bounding lines in both figures represent the 95 per cent confidence intervals of the
survival curves. We see that those in high complier superclass and perfect complier PS have
higher probabilities of survival than those in increasing noncomplier superclass or non-perfect
complier PS.
We fitted the Cox proportional hazards model using the latent compliance superclass as the
independent variable. We found that those in the high complier superclass are less likely to die
than those in the increasing noncomplier superclass (hazard ratio: 0.32 (0.15, 0.68)). We applied
Figure 1. Multiple imputation Kaplan–Meier survival curves by latent compliance superclass
with 95 per cent confidence intervals.
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Figure 2. Multiple imputation Kaplan–Meier survival curves by observed compliance PS with
95 per cent confidence intervals (intervention arm only).
the same Cox model to observed compliance PS and found that perfect compliers are also less
likely to die than non-perfect compliers (hazard ratio: 0.29 (0.13, 0.67)).
High compliers randomized to the intervention arm are more likely to receive the intervention
than increasing noncompliers randomized to the intervention arm. A model with main effects
of randomization and latent compliance superclass, and the interaction between randomization
and superclass shows that the interaction is not a significant predictor of mortality. This suggests
that mortality is associated with underlying patient compliance tendencies rather than the actual
intervention received.
5. DISCUSSION
In this paper, we presented a MCC model in the principal stratification framework to charac-
terize subject longitudinal compliance patterns. The method was discussed in the context of the
PROSPECT where subjects were randomized once at baseline and randomization status remained
the same throughout the study. Interventions were applied repeatedly over time and subject adher-
ence to their randomized intervention arm was measured at five follow-up time points and may
vary over time. In the PROSPECT, those randomized to the usual care arm have no access to the
intervention; therefore, yields only two possible compliance classes: compliers and never-takers.
Two compliance classes and five measurement times yield 32 (25) possible longitudinal compliance
patterns. We use broader compliance PS, or ‘compliance superclasses’, to describe the longitudinal
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compliance patterns present in the data. The time-varying compliance classes are modeled to be
dependent on the history of compliance behavior, or more specifically, the compliance class in the
previous follow-up.
The analyses utilized the principal stratification framework to relate post-randomization factors
to outcomes. Specifically, we used latent compliance superclasses to describe longitudinal pro-
files of intervention adherence. An advantage of using the proposed latent compliance superclass
compared to using observed adherence to the intervention is that superclasses are considered pre-
randomization factors, thus allowing us to examine the relationship between post-randomization
intervention adherence and outcomes.
PS also provide simple classification for summarizing different longitudinal compliance patterns.
In PROSPECT, there are 32 possible longitudinal compliance patterns. It may not be clinically
useful to examine subject characteristics and outcomes within each of the compliance patterns, and
such inferences may be sensitive to model assumptions when the number of subjects exhibiting the
patterns is small. We used two latent compliance superclasses to describe the compliance patterns
in the data.
We examined the relationship between the latent compliance superclass and baseline patient
characteristics. It may be useful for clinicians to be able to identify patients with different com-
pliance tendencies. Targeting patients who are more likely to adhere to particular interventions
allows clinicians to tailor interventions to patients and optimize patient adherence and outcomes.
The ability to identify patients who are less likely to adhere to particular interventions will alleviate
inefficient use of clinical staff time and medical resources. The intervention in the PROSPECT
entails meeting with health specialists. In this analysis we find that those in better physical health,
indicated by higher SF-36 physical component scores, are more likely to comply with the inter-
vention arm to which they are randomized over time. It may be easier for those in good physical
health to attend meetings with health specialists than those in bad physical health.
We also examined the relationship between the latent compliance superclass and all-cause
mortality. The analysis based on the latent compliance superclass and based on the observed
compliance PS both showed that higher compliance are associated with lower mortality. In addition,
this relationship is unlikely to be explained by the receipt of the intervention. This association
between subject compliance and mortality was also found in other studies [10–13], although these
studies were based on observed post-randomization intervention adherence rather than baseline
compliance PS. There may be some underlying factors associated with a person’s tendency to
comply with treatment and mortality. Simpson et al. [13] suggested that subject treatment adherence
may be a surrogate marker for overall healthy behavior.
A reviewer raised the point that the association between compliance and mortality may be due
to the association between higher compliance and better physical health. It is also possible that
compliance is related to innate traits that promote healthy behaviors and vitality. While our current
methodology allows us to examine the associations between compliance, patient characteristics,
and mortality, it does not tell us why certain compliance patterns lead to lower mortality. However,
the findings may still serve as an useful tool for characterizing groups of subjects for whom the
intervention may be successful, and characterizing subjects who may be at risk for treatment
noncompliance and mortality.
In studies where subjects randomized to the usual care arm have no access to the intervention,
compliance classes are observed in those randomized to the intervention arm. We could compare
baseline subject characteristics and outcomes in the subset of subjects who are randomized to the
intervention arm. However, note that the confidence intervals associated with the odds ratios when
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looking at the baseline covariates and the hazard ratios in the mortality analysis are narrower for
the estimates based on the latent compliance superclass than the estimates based on the observed
compliance PS. Utilizing latent principal stratification strategy in forming compliance classes
allows the inclusion of usual care subjects in the analysis, thus increase efficiency in the estimates
as demonstrated in our analyses and also potentially reducing bias.
The MCC model described in stage 1 of the analysis method section is computationally
intensive. In this paper, we performed a three-stage ad hoc analysis comparing baseline subject
characteristics and mortality between the latent compliance superclasses. We treat the superclass
assignment as missing data and multiply impute superclasses from the subject-level posterior pre-
dictive distribution of belonging to a given superclass. This type of analysis provides a fast way to
pinpoint possible predictors of longitudinal compliance and the effect of longitudinal compliance
on subsequent outcomes such as mortality. Ideally, we want to incorporate these predictors into
the MCC model. Future research will entail fitting the MCC model using physical health as a
predictor of the compliance superclass, and using both depression severity and mortality as joint
outcomes.
APPENDIX
We describe the priors used in the stage 1 MCMC estimation of the model parameters.
Let 	=[1c0, . . . , 5n1, c]T denote the fixed effects. We assume the conjugate priors 	 ∼
MVN(	,	) and 
2 ∼ Inv − 2(df= ,). We assume ui ∼MVN(0,) for the subject-level
random effects, and the hyperprior  ∼ Inv−Wishart(df= , ). For compliance superclass and
compliance class probabilities, we assume the priors (p1, p2) ∼Dirichlet(a1, a2), a∼MVN(0,),
and (k j′c, k j′n) ∼Dirichlet(bc, bn) ∀k, j, ′ where k denotes the kth superclass.
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